Bellicum Pharma (BLCM) Up 140% In A Month, To Report BPX-601 Data On Jan.24

Shares of Bellicum Pharmaceuticals Inc. (BLCM) have gained more than 140% over the last 1 month as the Company gears up to present new data related to its autologous GoCAR-T product candidate BPX-601.

from RTT - Biotech https://ift.tt/2RypgOy
via IFTTT